Drug Profile
Research programme: oral influenza vaccine - Oramed
Alternative Names: ORMD 1001Latest Information Update: 12 Sep 2013
Price :
$50
*
At a glance
- Originator Oramed Pharmaceuticals
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 12 Sep 2013 Discontinued - Preclinical for Influenza virus infections in Israel (PO)
- 10 Mar 2011 No development reported - Preclinical for Influenza virus infections in Israel (PO)
- 09 Feb 2009 Preclinical trials in Influenza virus infections in Israel (PO)